Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the safety and efficacy of CC-93538 in adult and adolescent participants with eosinophilic gastroenteritis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05214768
Study type Interventional
Source Celgene
Contact
Status Active, not recruiting
Phase Phase 3
Start date March 4, 2022
Completion date November 19, 2026

See also
  Status Clinical Trial Phase
Completed NCT03320369 - Effect of Elemental Diet on Adult Patients With Eosinophilic Gastroenteritis N/A
Completed NCT00148603 - Montelukast in the Treatment of Duodenal Eosinophilia N/A
Completed NCT03664960 - An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis Phase 2
Completed NCT00267475 - Data Bank for Eosinophilic Disorders N/A
Completed NCT04856891 - A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis Phase 3
Active, not recruiting NCT03678545 - Dupilumab in Eosinophilic Gastritis Phase 2
Terminated NCT01814059 - Sirolimus for Eosinophil-Associated Gastrointestinal Disorders Phase 1
Recruiting NCT01793168 - Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Completed NCT03496571 - A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis Phase 2
Recruiting NCT02523118 - OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
Completed NCT05251909 - Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study) Phase 3
Completed NCT05439772 - Examining the Effect of Ondansetron on Bowel Prep Success Phase 4
Completed NCT00266565 - Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome Phase 1/Phase 2
Recruiting NCT05199532 - Eosinophilic Gastrointestinal Disorders Registry
Terminated NCT01212016 - Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders N/A
Completed NCT02897271 - Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort